Public Comments: December 2006 – Medical privacy / Medicare Part D World Privacy Forum Requests That CMS Bring Its Medicare Part D Data Activities Under HIPAA and Require Certificates of Confidentiality to Protect Patient Privacy

In comments filed with the Centers for Medicare and Medicaid Services, the World Privacy Forum requested that CMS give effect to data restrictions that Congress has expressly included in the law. WPF also requested that CMS include in its standard agreements for use of CMS data a requirement that the recipient obtain a certification of confidentiality for all identifiable CMS data. WPF also requested that CMS perform a regulatory impact analysis and publish a system of records notice.

Identity Theft Victims of Choicepoint Data Breach May Now File Reimbursement Claims

Identity theft | Consumer Alert — The Federal Trade Commission has set up a new web site and phone number for identity theft victims of the Choicepoint data breach. The new site and phone number gives victims information on how to file claims for monetary reimbursement if out- of- pocket losses accrued as a result of the ID theft. A fund of $5 million is available to victims, the deadline for filing is February 4, 2007.

Department of Justice Proposes Making Changes to Routine Uses of its Systems and Databases; World Privacy Forum Files Comments on Problematic Privacy Act Issues with the Proposed Changes

Privacy Act of 1974 — The Department of Justice published a notice proposing to update the Routine Uses of its systems and databases under the Privacy Act of 1974. The proposal was not precise enough, and was written in such a way as to allow sensitive Privacy Act systems such as the Criminal Division Witness Security File (CRM-002), the Witness Immunity Records (CRM-022), and the National Instant Criminal Background Check System (NICS, FBI-018) to be disclosed to almost anyone in certain circumstances, including to individuals working outside of law enforcement. The World Privacy Forum is requesting that the DOJ significantly tighten its language in the proposal, and to specify what individuals or entities may have access to these sensitive records, under what specific conditions. The World Privacy Forum is also requesting the DOJ republish all of its up-to-date system of records notices in their entirety immediately and at least every two years thereafter.

Public Comments: November 2006 – Privacy Act of 1974 Department of Justice Proposes Making Changes to Routine Uses of its Systems and Databases; World Privacy Forum Files Comments on Problematic Privacy Act Issues with the Proposed Changes

The Department of Justice published a notice proposing to update the Routine Uses of its systems and databases under the Privacy Act of 1974. The proposal was not precise enough, and was written in such a way as to allow sensitive Privacy Act systems such as the Criminal Division Witness Security File (CRM-002), the Witness Immunity Records (CRM-022), and the National Instant Criminal Background Check System (NICS, FBI-018) to be disclosed to almost anyone in certain circumstances, including to individuals working outside of law enforcement. The World Privacy Forum is requesting that the DOJ significantly tighten its language in the proposal, and to specify what individuals or entities may have access to these sensitive records, under what specific conditions. The World Privacy Forum is also requesting the DOJ republish all of its up-to-date system of records notices in their entirety immediately and at least every two years thereafter. Read the comments (PDF).

World Privacy Forum Comments on Proposed Policy for Genetic Database

Genetic privacy — Genome-wide association studies present complex and challenging privacy issues. The National Institutes of Health, in a published request for information, asked for public comment on its proposed policy regarding its support and management of a central genomic repository for genome-wide association studies. In comments filed with the National Institutes of Health, the World Privacy Forum raised concerns about the proposed NIH policy in the specific areas of genetic identifiability, secondary uses of the genetic data, oversight, legal protections, and informed consent.